ArticleFrontiers in oncology2026
TNM staging of esophageal cancer using fine-tuned pathology foundation models and multiple instance learning.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Esophageal cancer is a common and aggressive malignancy worldwide. Accurate TNM staging is essential for clinical decision-making and prognosis. While whole slide images (WSIs) offer rich histopathological details for automated staging, their sheer size and complexity make manual analysis subjective and time-consuming. Consequently, advanced deep learning models are critically needed to improve the accuracy and efficiency of WSI-based TNM staging. Methods: We propose a novel deep learning approach that integrates a fine-tuned pathology foundation model within a Multiple Instance Learning (MIL) framework for automated TNM staging from WSIs. To boost predictive accuracy, our model is enhanced with a feature attention mechanism to pinpoint critical tumor areas and an adaptive layer for effective multi-scale feature fusion. Furthermore, we developed a class-weighted cross-entropy loss function to address pronounced TNM stage imbalance, targeting composite pathological stage classification as a single multi-class prediction task rather than separate T, N, and M components. Performance was rigorously evaluated using three-fold cross-validation and benchmarked against state-of-the-art methods. Results: Our model achieved outstanding performance on the TCGA-ESCA dataset, outperforming existing methods in accuracy, macro F1-score, and AUC. These results confirm the model's effectiveness. Visualization analysis further showed that the model accurately localizes tumor regions and their boundaries, increasing the interpretability and reliability of its predictions. Conclusion: Our study validates the potential of a WSI-based deep learning approach for accurate prediction of esophageal cancer's TNM stage. This tool has the potential to augment pathological diagnosis, refine patient risk assessment, and ultimately guide better treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.